- Home
- TNGX vs CNX Comparison
TNGX vs CNX Comparison
Compare TNGX & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | CNX |
|---|---|---|
| Founded | 2014 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.8B |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | TNGX | CNX |
|---|---|---|
| Price | $28.61 | $34.45 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 7 |
| Target Price | $21.78 | ★ $35.71 |
| AVG Volume (30 Days) | ★ 2.2M | 1.7M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.89 | ★ 763.33 |
| EPS | N/A | ★ 3.56 |
| Revenue | $62,384,000.00 | ★ $2,239,134,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.14 |
| P/E Ratio | ★ N/A | $10.01 |
| Revenue Growth | 48.29 | ★ 76.76 |
| 52 Week Low | $6.25 | $27.72 |
| 52 Week High | $34.39 | $43.62 |
Technical Indicators
Market Signals| Indicator | TNGX | CNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.54 | 54.54 |
| Support Level | $27.79 | $33.33 |
| Resistance Level | $33.96 | $37.67 |
| Average True Range (ATR) | 1.64 | 1.03 |
| MACD | 0.06 | 0.21 |
| Stochastic Oscillator | 74.19 | 61.66 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CNX CNX Resources Corporation
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.